Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.11
-0.08 (-1.11%)
At close: Aug 14, 2025, 3:59 PM
7.12
0.14%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Amicus Therapeutics Revenue

Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending June 30, 2025, Amicus Therapeutics generated $154.69M in revenue.
Revenue (ttm)
528.29M
Revenue Growth
32.29%
Price / Sales Ratio
5.43
Revenue / Employee
1.06M
Employees
499
Market Cap
2.19B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.